Cell-based therapies are not conventional drugs, they are living drugs
...requiring cutting-edge expertise in Cell Biology
The European Cell Therapy CDMO Bridging Science and GMP compliance.
- 300+ cumulated years of cell culture experience;
- Beyond technological expertise, rely on our know-how to guarantee aseptic practices.;
- Leverage on our knowledge on Adherent, non-Adherent cell types, engineered or not.
- Beyond technological expertise, rely on our know-how to guarantee aseptic practices.;
- Leverage on our knowledge on Adherent, non-Adherent cell types, engineered or not.
- Bridge VARIABILITY inherent to living drugs and RIGIDITY of GMP practices.
- From concept to First-in-Human and beyond;
- Regulatory adapted to cell products
- Anticipate Risks & Gaps to fill before cGMP implementation;
- Co-define a robust roadmap;
- Pick the best practices and leave the superfluous behind;
- Accelerate Process Development/Scale-up;
- Enhanced ATMP characterization;
- Access expertise on 50+ different technologies;
- Benefits from pre-established discounts with our providers;
- Beyond agreements (NDA, MSA, QTA) our internal confidential policy protect your industrial secret;
- As a fee for service CDMO, no IP is shared
- All documentation/production is Yours;
- Your Challenges = Our Solutions;
- Dedicated Project Manager;
- Weekly operational meetings;
- Monthly steering comitee meetings
0
+
GMP Clinical batches produced
0
+
Cell types: T-Cells, NK-Cells, iPS Cells, MSCs, immortalized cell lines
0
+
Process & Anaytical method Development Programs
0
cGMP cleanrooms
What's new at Cell-Easy
News
May 14, 2024
No Comments
Contact
Tel : +33 534 276 550
Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
Mail : info@cell-easy.com